Exelixis, Inc. (EXEL)
USD 34.69
(-5.44%)
USD 34.69
(-5.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 678.44 Million USD | 16.36% |
| 2022 | 583.06 Million USD | 43.74% |
| 2021 | 405.62 Million USD | 57.08% |
| 2020 | 258.22 Million USD | 29.3% |
| 2019 | 199.7 Million USD | 48.11% |
| 2018 | 134.83 Million USD | -63.59% |
| 2017 | 370.33 Million USD | -27.13% |
| 2016 | 508.22 Million USD | 16.39% |
| 2015 | 436.64 Million USD | -1.39% |
| 2014 | 442.78 Million USD | 1.31% |
| 2013 | 437.04 Million USD | 2.92% |
| 2012 | 424.66 Million USD | 40.32% |
| 2011 | 302.63 Million USD | -48.63% |
| 2010 | 589.11 Million USD | 16.17% |
| 2009 | 507.13 Million USD | 10.76% |
| 2008 | 457.88 Million USD | 40.19% |
| 2007 | 326.6 Million USD | 7.15% |
| 2006 | 304.8 Million USD | 10.67% |
| 2005 | 275.41 Million USD | 14.44% |
| 2004 | 240.66 Million USD | 22.6% |
| 2003 | 196.31 Million USD | 20.29% |
| 2002 | 163.19 Million USD | 49.18% |
| 2001 | 109.39 Million USD | 165.93% |
| 2000 | 41.13 Million USD | 89.57% |
| 1999 | 21.7 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 684.85 Million USD | 4.82% |
| 2024 Q1 | 675.74 Million USD | -0.4% |
| 2024 Q2 | 653.38 Million USD | -3.31% |
| 2023 Q3 | 629.29 Million USD | 2.4% |
| 2023 Q4 | 678.44 Million USD | 7.81% |
| 2023 Q2 | 614.53 Million USD | 4.47% |
| 2023 Q1 | 588.22 Million USD | 0.89% |
| 2023 FY | 678.44 Million USD | 16.36% |
| 2022 Q4 | 583.06 Million USD | 24.06% |
| 2022 FY | 583.06 Million USD | 43.74% |
| 2022 Q1 | 360.26 Million USD | -11.18% |
| 2022 Q2 | 490.14 Million USD | 36.05% |
| 2022 Q3 | 469.97 Million USD | -4.12% |
| 2021 Q1 | 279.35 Million USD | 8.18% |
| 2021 Q2 | 324.19 Million USD | 16.05% |
| 2021 FY | 405.62 Million USD | 57.08% |
| 2021 Q4 | 405.62 Million USD | 20.98% |
| 2021 Q3 | 335.29 Million USD | 3.42% |
| 2020 Q3 | 259.01 Million USD | 21.47% |
| 2020 Q4 | 258.22 Million USD | -0.31% |
| 2020 FY | 258.22 Million USD | 29.3% |
| 2020 Q1 | 207.95 Million USD | 4.13% |
| 2020 Q2 | 213.22 Million USD | 2.54% |
| 2019 Q2 | 154.46 Million USD | -1.47% |
| 2019 FY | 199.7 Million USD | 48.11% |
| 2019 Q1 | 156.77 Million USD | 16.27% |
| 2019 Q4 | 199.7 Million USD | 10.24% |
| 2019 Q3 | 181.14 Million USD | 17.27% |
| 2018 Q3 | 108.4 Million USD | -20.41% |
| 2018 FY | 134.83 Million USD | -63.59% |
| 2018 Q4 | 134.83 Million USD | 24.38% |
| 2018 Q2 | 136.19 Million USD | 29.52% |
| 2018 Q1 | 105.14 Million USD | -71.61% |
| 2017 Q3 | 371.05 Million USD | 0.82% |
| 2017 Q1 | 467.23 Million USD | -8.07% |
| 2017 FY | 370.33 Million USD | -27.13% |
| 2017 Q4 | 370.33 Million USD | -0.2% |
| 2017 Q2 | 368.02 Million USD | -21.23% |
| 2016 Q3 | 516.46 Million USD | -22.13% |
| 2016 Q4 | 508.22 Million USD | -1.6% |
| 2016 Q1 | 648.48 Million USD | 48.52% |
| 2016 Q2 | 663.27 Million USD | 2.28% |
| 2016 FY | 508.22 Million USD | 16.39% |
| 2015 Q3 | 437.46 Million USD | 0.12% |
| 2015 Q4 | 436.64 Million USD | -0.19% |
| 2015 Q1 | 429.69 Million USD | -2.96% |
| 2015 FY | 436.64 Million USD | -1.39% |
| 2015 Q2 | 436.96 Million USD | 1.69% |
| 2014 Q1 | 426.08 Million USD | -2.51% |
| 2014 FY | 442.78 Million USD | 1.31% |
| 2014 Q3 | 442.16 Million USD | 1.09% |
| 2014 Q4 | 442.78 Million USD | 0.14% |
| 2014 Q2 | 437.39 Million USD | 2.65% |
| 2013 Q3 | 423.19 Million USD | 1.79% |
| 2013 Q2 | 415.75 Million USD | 2.74% |
| 2013 Q1 | 404.67 Million USD | -4.71% |
| 2013 FY | 437.04 Million USD | 2.92% |
| 2013 Q4 | 437.04 Million USD | 3.27% |
| 2012 FY | 424.66 Million USD | 40.32% |
| 2012 Q1 | 280.25 Million USD | -7.39% |
| 2012 Q2 | 275.43 Million USD | -1.72% |
| 2012 Q3 | 421.76 Million USD | 53.13% |
| 2012 Q4 | 424.66 Million USD | 0.69% |
| 2011 FY | 302.63 Million USD | -48.63% |
| 2011 Q4 | 302.63 Million USD | -25.93% |
| 2011 Q3 | 408.58 Million USD | -23.77% |
| 2011 Q2 | 535.99 Million USD | -5.05% |
| 2011 Q1 | 564.48 Million USD | -4.18% |
| 2010 FY | 589.11 Million USD | 16.17% |
| 2010 Q3 | 590.49 Million USD | -6.92% |
| 2010 Q1 | 483.5 Million USD | -4.66% |
| 2010 Q4 | 589.11 Million USD | -0.23% |
| 2010 Q2 | 634.41 Million USD | 31.21% |
| 2009 Q4 | 507.13 Million USD | -10.06% |
| 2009 Q3 | 563.87 Million USD | 23.44% |
| 2009 FY | 507.13 Million USD | 10.76% |
| 2009 Q2 | 456.79 Million USD | 2.87% |
| 2009 Q1 | 444.05 Million USD | -3.02% |
| 2008 Q3 | 278.21 Million USD | -8.65% |
| 2008 Q4 | 457.88 Million USD | 64.58% |
| 2008 Q1 | 321.17 Million USD | -1.66% |
| 2008 FY | 457.88 Million USD | 40.19% |
| 2008 Q2 | 304.56 Million USD | -5.17% |
| 2007 Q4 | 326.6 Million USD | 2.17% |
| 2007 Q1 | 351.16 Million USD | 15.21% |
| 2007 Q3 | 319.65 Million USD | -2.54% |
| 2007 FY | 326.6 Million USD | 7.15% |
| 2007 Q2 | 327.98 Million USD | -6.6% |
| 2006 Q4 | 304.8 Million USD | 24.25% |
| 2006 FY | 304.8 Million USD | 10.67% |
| 2006 Q3 | 245.32 Million USD | -3.8% |
| 2006 Q2 | 255.01 Million USD | -15.85% |
| 2006 Q1 | 303.06 Million USD | 10.04% |
| 2005 Q1 | 236.64 Million USD | -1.67% |
| 2005 Q2 | 262.93 Million USD | 11.11% |
| 2005 Q4 | 275.41 Million USD | 8.36% |
| 2005 Q3 | 254.15 Million USD | -3.34% |
| 2005 FY | 275.41 Million USD | 14.44% |
| 2004 Q3 | 187.2 Million USD | 3.96% |
| 2004 Q4 | 240.66 Million USD | 28.56% |
| 2004 Q1 | 187.01 Million USD | -4.74% |
| 2004 FY | 240.66 Million USD | 22.6% |
| 2004 Q2 | 180.07 Million USD | -3.71% |
| 2003 Q4 | 196.31 Million USD | 28.0% |
| 2003 FY | 196.31 Million USD | 20.29% |
| 2003 Q1 | 165.29 Million USD | 1.29% |
| 2003 Q2 | 158.76 Million USD | -3.95% |
| 2003 Q3 | 153.37 Million USD | -3.4% |
| 2002 Q4 | 163.19 Million USD | 79.03% |
| 2002 FY | 163.19 Million USD | 49.18% |
| 2002 Q1 | 91.51 Million USD | -16.35% |
| 2002 Q2 | 89.44 Million USD | -2.26% |
| 2002 Q3 | 91.15 Million USD | 1.92% |
| 2001 Q1 | 43.77 Million USD | 6.42% |
| 2001 FY | 109.39 Million USD | 165.93% |
| 2001 Q3 | 97.3 Million USD | 14.49% |
| 2001 Q4 | 109.39 Million USD | 12.42% |
| 2001 Q2 | 84.99 Million USD | 94.15% |
| 2000 Q3 | 29.14 Million USD | -13.67% |
| 2000 Q2 | 33.75 Million USD | -5.5% |
| 2000 Q1 | 35.72 Million USD | 0.0% |
| 2000 Q4 | 41.13 Million USD | 41.17% |
| 2000 FY | 41.13 Million USD | 89.57% |
| 1999 FY | 21.7 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -102.053% |
| Alkermes plc | 933.53 Million USD | 27.325% |
| Agenus Inc. | 462.29 Million USD | -46.756% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 83.25% |
| Aptorum Group Limited | 5.25 Million USD | -12806.198% |
| Ardelyx, Inc. | 130.76 Million USD | -418.836% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -41.818% |
| Bicycle Therapeutics plc | 224.41 Million USD | -202.321% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -421.039% |
| ChromaDex Corporation | 26.5 Million USD | -2459.397% |
| Chimerix, Inc. | 19.74 Million USD | -3336.034% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1828.654% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -834.922% |
| CRISPR Therapeutics AG | 346.76 Million USD | -95.648% |
| Precision BioSciences, Inc. | 140.92 Million USD | -381.44% |
| Dyadic International, Inc. | 2.34 Million USD | -28885.312% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -4071.709% |
| Fortress Biotech, Inc. | 165.93 Million USD | -308.852% |
| Lantern Pharma Inc. | 2.73 Million USD | -24663.64% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -849.14% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -19126.349% |
| Incyte Corporation | 1.59 Billion USD | 57.391% |
| IO Biotech, Inc. | 17.55 Million USD | -3764.462% |
| Jaguar Health, Inc. | 45.86 Million USD | -1379.189% |
| Novavax, Inc. | 2.57 Billion USD | 73.625% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1781.538% |
| Opthea Limited | 264.6 Million USD | -156.403% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -419.058% |
| ContextLogic Inc. | 206 Million USD | -229.342% |
| MiMedx Group, Inc. | 96.33 Million USD | -604.293% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1312.78% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -19125.467% |
| NextCure, Inc. | 14.99 Million USD | -4423.871% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -16684.884% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -10060.926% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1351.561% |
| Vaxcyte, Inc. | 167.44 Million USD | -305.165% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1939.876% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -188.437% |
| Pharming Group N.V. | 244.07 Million USD | -177.968% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5590.698% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -430.902% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10168.145% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10168.145% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -723.026% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -10112.931% |
| Acelyrin, Inc. | 86.35 Million USD | -685.665% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -52118.565% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4618.304% |
| Summit Therapeutics Inc. | 125.25 Million USD | -441.642% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -7057.348% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1190.531% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -886.442% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -347.783% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -34585.327% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -50698.389% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -199.096% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -7142.927% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -198.29% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -37.196% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -6116.282% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2366.086% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5504.807% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -39.425% |
| Immix Biopharma, Inc. | 3.72 Million USD | -18129.032% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1694.258% |
| MEI Pharma, Inc. | 8.35 Million USD | -8020.227% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2238.256% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -95.191% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -365.106% |
| Fortress Biotech, Inc. | 165.93 Million USD | -308.852% |
| Precigen, Inc. | 41.64 Million USD | -1529.154% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1258.792% |
| AlloVir, Inc. | 45.01 Million USD | -1407.153% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -420.531% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -392.34% |
| ImmuCell Corporation | 18.81 Million USD | -3505.868% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2303.617% |
| Onconetix, Inc. | 23.18 Million USD | -2826.743% |
| PureTech Health plc | 125.58 Million USD | -440.236% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -7480.391% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1879.012% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -27648.262% |
| Seer, Inc. | 39.36 Million USD | -1623.473% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -997.204% |
| Innoviva, Inc. | 568.55 Million USD | -19.329% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2391.718% |
| ESSA Pharma Inc. | 3.49 Million USD | -19311.48% |
| GlycoMimetics, Inc. | 6.9 Million USD | -9729.582% |
| GT Biopharma, Inc. | 6.63 Million USD | -10128.328% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -156.608% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -149.165% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -707.423% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -6841.324% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2397.129% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -20932.013% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -819.713% |
| Aptose Biosciences Inc. | 15.8 Million USD | -4191.592% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -6045.51% |
| Soligenix, Inc. | 7.27 Million USD | -9225.828% |
| Century Therapeutics, Inc. | 175.94 Million USD | -285.609% |
| Kura Oncology, Inc. | 51.66 Million USD | -1213.238% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -459.395% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -16315.316% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -10157.936% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -168.587% |
| Autolus Therapeutics plc | 263.9 Million USD | -157.077% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -6372.477% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -663.49% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1346.609% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -92.272% |
| GRI Bio, Inc. | 2.69 Million USD | -25055.543% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -83701.577% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2082.127% |
| IGM Biosciences, Inc. | 220.17 Million USD | -208.136% |
| INmune Bio, Inc. | 18.86 Million USD | -3496.888% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -164.523% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2446.542% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -24857.457% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -20582.621% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1060.628% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -605.545% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -156.273% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 17.567% |
| Verastem, Inc. | 71.18 Million USD | -853.073% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1279.626% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1658.632% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1286.506% |
| Histogen Inc. | 5.69 Million USD | -11808.812% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -15369.815% |
| Surrozen, Inc. | 8.14 Million USD | -8229.589% |
| Organovo Holdings, Inc. | 2.74 Million USD | -24588.683% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -216063.042% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1106.556% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -4008.8% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1227.603% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -81949.282% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -435.368% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -6174.003% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -349.632% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -25920.53% |
| Apollomics, Inc. | 14.15 Million USD | -4693.648% |
| Amarin Corporation plc | 279.58 Million USD | -142.66% |
| Mesoblast Limited | 188.79 Million USD | -259.35% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4695.342% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -275.271% |
| Synaptogenix, Inc. | 5.52 Million USD | -12169.623% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -10105.25% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -298.832% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7828.359% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -38505.195% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2745.588% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -313.57% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -14.176% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6252.36% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -41686.05% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1642.865% |
| Gritstone bio, Inc. | 125.91 Million USD | -438.795% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4522.82% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -13232.575% |
| Avid Bioservices, Inc. | 275.66 Million USD | -146.109% |
| Insmed Incorporated | 1.66 Billion USD | 59.173% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -8717.818% |
| MediWound Ltd. | 27.18 Million USD | -2395.476% |
| OmniAb, Inc. | 87.4 Million USD | -676.253% |
| Alector, Inc. | 487.66 Million USD | -39.12% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -68.158% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3582.198% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1668.027% |
| Zai Lab Limited | 240.17 Million USD | -182.477% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -7.68% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2221.295% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -613.574% |
| Immunic, Inc. | 25.36 Million USD | -2574.413% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -879.902% |
| Veracyte, Inc. | 93.71 Million USD | -623.914% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -25827.772% |
| FibroGen, Inc. | 585.72 Million USD | -15.829% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3802.922% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -103784.54% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -11896.287% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 91.139% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -8175.738% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -707.461% |
| TG Therapeutics, Inc. | 169.08 Million USD | -301.245% |
| Galecto, Inc. | 5.89 Million USD | -11406.869% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -8089.824% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 74.089% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2253.914% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -5275.525% |
| XBiotech Inc. | 8.39 Million USD | -7979.612% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4522.82% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1175.752% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -86.845% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2423.601% |
| Theravance Biopharma, Inc. | 169 Million USD | -301.437% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 44.188% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -35.573% |
| Vaxxinity, Inc. | 30.94 Million USD | -2092.493% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 30.236% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -11149.096% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 8.962% |
| NexImmune, Inc. | 5.08 Million USD | -13244.1% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -182575.272% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -21964.343% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 90.454% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -13063.389% |
| Scopus BioPharma Inc. | 7.45 Million USD | -9001.228% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2480.227% |
| Ainos, Inc. | 7.39 Million USD | -9075.339% |
| Pluri Inc. | 34.11 Million USD | -1888.875% |
| Prothena Corporation plc | 135.01 Million USD | -402.489% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -179.077% |
| Celularity Inc. | 102.92 Million USD | -559.139% |
| Rallybio Corporation | 9.43 Million USD | -7089.964% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2675.394% |
| MeiraGTx Holdings plc | 319.99 Million USD | -112.02% |
| Omeros Corporation | 403.25 Million USD | -68.243% |
| Humacyte, Inc. | 114.67 Million USD | -491.614% |
| Immunocore Holdings plc | 228.15 Million USD | -197.358% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -13816.821% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -784.083% |
| Blueprint Medicines Corporation | 918.64 Million USD | 26.147% |
| CalciMedica, Inc. | 4.02 Million USD | -16743.222% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3787.491% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -340.14% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -690.572% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -144.227% |
| Pulmatrix, Inc. | 15.96 Million USD | -4150.11% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -4201.306% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2657.234% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -170.504% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1235.89% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 43.96% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2034.616% |
| Nutriband Inc. | 1.07 Million USD | -62781.922% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -6280.561% |
| Vor Biopharma Inc. | 59.1 Million USD | -1047.883% |
| Roivant Sciences Ltd. | 773.95 Million USD | 12.34% |
| Evogene Ltd. | 17.99 Million USD | -3671.234% |
| ProKidney Corp. | 29.21 Million USD | -2222.169% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -842.56% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -96135.654% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 64.083% |
| CorMedix Inc. | 11.91 Million USD | -5592.833% |
| BioLineRx Ltd. | 50.7 Million USD | -1238.103% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -353.934% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -667.116% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1280.019% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2077.832% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3677.113% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -444.341% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -11899.381% |
| MediciNova, Inc. | 3.89 Million USD | -17333.785% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3611.609% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -45002.148% |
| GeoVax Labs, Inc. | 3.51 Million USD | -19174.657% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -70.782% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2110.639% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 75.073% |
| Mereo BioPharma Group plc | 15.96 Million USD | -4150.376% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2074.434% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1056.099% |
| Absci Corporation | 58.3 Million USD | -1063.634% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3461.765% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2016.041% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -819.427% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -675.516% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1909.017% |
| Allakos Inc. | 74.79 Million USD | -807.097% |
| Imunon, Inc. | 8.53 Million USD | -7853.236% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2915.177% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -490.918% |
| BioAtla, Inc. | 48.98 Million USD | -1284.977% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6252.36% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -24313.278% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -419.467% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4672.74% |
| XOMA Corporation | 145.58 Million USD | -366.029% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1915.283% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -886.7% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2047.182% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -997.399% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1408.829% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1301.688% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -23539.199% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -8216.297% |
| Akari Therapeutics, Plc | 4.58 Million USD | -14700.284% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3725.862% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 58.869% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -167870.181% |
| UroGen Pharma Ltd. | 243.52 Million USD | -178.596% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -111.296% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -24467.472% |
| Orgenesis Inc. | 35.53 Million USD | -1809.23% |
| Entera Bio Ltd. | 1.37 Million USD | -49098.332% |
| GH Research PLC | 6.7 Million USD | -10024.534% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -9877.132% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3503.766% |
| Xencor, Inc. | 283.55 Million USD | -139.261% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -22623.337% |
| Replimune Group, Inc. | 113.21 Million USD | -499.259% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -17957.557% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -555.312% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -167870.181% |
| Portage Biotech Inc. | 4.45 Million USD | -15145.955% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -45002.148% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2843.362% |
| OncoCyte Corporation | 49.29 Million USD | -1276.212% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -16300.217% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -84973.18% |
| Purple Biotech Ltd. | 10 Million USD | -6681.059% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -11625.631% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1084.829% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -5376.621% |
| HilleVax, Inc. | 78.9 Million USD | -759.782% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -13334.554% |
| Tharimmune, Inc. | 1.81 Million USD | -37278.942% |
| Genprex, Inc. | 3.25 Million USD | -20748.237% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2401.733% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -12857.315% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -329242.233% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -189120.132% |
| OKYO Pharma Limited | 7.42 Million USD | -9042.421% |
| Savara Inc. | 37.19 Million USD | -1724.169% |
| Curis, Inc. | 57.61 Million USD | -1077.611% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2476.714% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1630.736% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -46883.726% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -3158.778% |
| BeiGene, Ltd. | 2.23 Billion USD | 69.627% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -3086.714% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -158.557% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -3089.081% |
| Erasca, Inc. | 78.61 Million USD | -763.041% |
| bluebird bio, Inc. | 424.62 Million USD | -59.775% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -103439.554% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 64.104% |
| DBV Technologies S.A. | 42.8 Million USD | -1485.152% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -103439.554% |
| Moderna, Inc. | 4.57 Billion USD | 85.161% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -9598.999% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -40868.901% |
| Molecular Templates, Inc. | 31.17 Million USD | -2076.526% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3874.487% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -15.362% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -444.914% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2372.738% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1760.997% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1119.457% |
| MacroGenics, Inc. | 154.2 Million USD | -339.957% |
| RenovoRx, Inc. | 4.46 Million USD | -15091.335% |
| Adicet Bio, Inc. | 37.12 Million USD | -1727.707% |
| Prime Medicine, Inc. | 60.78 Million USD | -1016.231% |
| Aditxt, Inc. | 28.53 Million USD | -2277.876% |
| Adagene Inc. | 45.16 Million USD | -1402.003% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -375351.713% |
| Quantum-Si incorporated | 26.63 Million USD | -2447.576% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 2.741% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -22199.386% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -490.152% |
| SciSparc Ltd. | 1.59 Million USD | -42435.737% |
| Vericel Corporation | 127.7 Million USD | -431.26% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12091.517% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -694.822% |
| Generation Bio Co. | 171.63 Million USD | -295.295% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5773.983% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1521.871% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -168.481% |
| Invivyd, Inc. | 51.71 Million USD | -1211.943% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -637.625% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -10329.19% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -798.65% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -66349.07% |
| 2seventy bio, Inc. | 310.12 Million USD | -118.764% |
| ADMA Biologics, Inc. | 193.97 Million USD | -249.757% |
| Clene Inc. | 38.95 Million USD | -1641.791% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1777.64% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -164.011% |
| GeoVax Labs, Inc. | 3.51 Million USD | -19174.657% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -256.583% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5470.311% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -242.093% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5463.396% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1310.166% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1183.937% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -83.436% |
| Evaxion Biotech A/S | 17.61 Million USD | -3750.976% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -321.58% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -342.89% |
| Trevena, Inc. | 48.26 Million USD | -1305.754% |
| Surrozen, Inc. | 8.14 Million USD | -8229.589% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -3041.676% |
| Cingulate Inc. | 10.36 Million USD | -6448.15% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -24570.727% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1719.278% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -18816.526% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -5059.278% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -113.885% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2630.271% |
| Clearmind Medicine Inc. | 3.61 Million USD | -18693.449% |
| Kronos Bio, Inc. | 54.2 Million USD | -1151.72% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1342.181% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2880.901% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3280.225% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2891.848% |
| ImmunityBio, Inc. | 1.09 Billion USD | 37.78% |
| Korro Bio, Inc. | 51.75 Million USD | -1210.954% |
| Kineta, Inc. | 7.22 Million USD | -9294.143% |
| BioVie Inc. | 9.7 Million USD | -6892.743% |
| Codexis, Inc. | 49.94 Million USD | -1258.357% |
| Celularity Inc. | 102.92 Million USD | -559.139% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -604.9% |
| Celcuity Inc. | 51.45 Million USD | -1218.647% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -196440.206% |
| Cibus, Inc. | 206.11 Million USD | -229.155% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1497.281% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2475.819% |
| IN8bio, Inc. | 8.77 Million USD | -7634.211% |
| Kodiak Sciences Inc. | 213.59 Million USD | -217.637% |
| Annexon, Inc. | 47.11 Million USD | -1339.885% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -657.692% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -603.986% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4856.133% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 73.94% |
| Eyenovia, Inc. | 19.78 Million USD | -3329.906% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -283.116% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8732.769% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2715.241% |
| Arcellx, Inc. | 339.75 Million USD | -99.688% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5602.177% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -176.307% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6994.479% |
| Moolec Science SA | 13.94 Million USD | -4765.025% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1472.221% |
| Geron Corporation | 146.12 Million USD | -364.284% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1242.605% |
| Royalty Pharma plc | 6.29 Billion USD | 89.227% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1605.664% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -230345.371% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -27475.904% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -258.67% |
| Humacyte, Inc. | 114.67 Million USD | -491.614% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2235.358% |
| 89bio, Inc. | 59.96 Million USD | -1031.439% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2463.749% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -56626.171% |
| Genelux Corporation | 8.42 Million USD | -7957.542% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -9795.639% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -397.689% |
| Notable Labs, Ltd. | 4.42 Million USD | -15225.164% |
| Liquidia Corporation | 73.13 Million USD | -827.623% |
| Mustang Bio, Inc. | 17.61 Million USD | -3750.644% |
| Immunovant, Inc. | 48.95 Million USD | -1285.854% |
| Quantum-Si incorporated | 26.63 Million USD | -2447.576% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1667.566% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -21764.164% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -818.543% |
| Acasti Pharma Inc. | 11.55 Million USD | -5770.425% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2900.943% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -24857.457% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1739.751% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -49681.633% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -11029.347% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2631.81% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2826.35% |
| PepGen Inc. | 34.63 Million USD | -1859.068% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5486.668% |
| United Therapeutics Corporation | 1.18 Billion USD | 42.612% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -9614.275% |
| Solid Biosciences Inc. | 38.45 Million USD | -1664.119% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7828.359% |
| Immuneering Corporation | 12 Million USD | -5549.775% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -216063.042% |
| Silo Pharma, Inc. | 1.56 Million USD | -43133.159% |
| Belite Bio, Inc | 4.21 Million USD | -16011.256% |
| XOMA Corporation | 145.58 Million USD | -366.029% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -27842.545% |
| Bionomics Limited | 10.15 Million USD | -6578.449% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -3056.88% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2860.961% |
| uniQure N.V. | 624.01 Million USD | -8.722% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4679.465% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -375351.713% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -298.654% |
| Forte Biosciences, Inc. | 3.66 Million USD | -18406.41% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -260256.585% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -9955.506% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8732.769% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3802.922% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -6319.805% |
| Altimmune, Inc. | 16.54 Million USD | -4001.596% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -9.833% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2860.961% |
| Compugen Ltd. | 55.77 Million USD | -1116.396% |
| Peak Bio, Inc. | 20.75 Million USD | -3169.084% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -514.183% |
| Benitec Biopharma Inc. | 4.96 Million USD | -13572.813% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -329.823% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -802.5% |
| Zura Bio Limited | 21.29 Million USD | -3086.385% |
| PolyPid Ltd. | 17.46 Million USD | -3783.931% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -503.604% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -802.5% |
| Instil Bio, Inc. | 99.8 Million USD | -579.798% |
| argenx SE | 444.95 Million USD | -52.476% |
| Immunome, Inc. | 28.65 Million USD | -2267.384% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -8037.759% |
| Verona Pharma plc | 58.84 Million USD | -1053.014% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4587.66% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4465.886% |
| CervoMed Inc. | 2.59 Million USD | -26036.792% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -13819.676% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -5226.986% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -6339.915% |
| Moolec Science SA | 13.94 Million USD | -4765.025% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -28850.025% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1120.328% |
| AnaptysBio, Inc. | 364.28 Million USD | -86.24% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5574.515% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -5248.825% |
| NeurAxis, Inc. | 1.91 Million USD | -35369.816% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1642.82% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4988.465% |
| Achilles Therapeutics plc | 19.08 Million USD | -3454.487% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4587.66% |
| 180 Life Sciences Corp. | 5.38 Million USD | -12493.627% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2776.231% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2880.901% |
| Nutriband Inc. | 1.07 Million USD | -62781.922% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2117.285% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4575.384% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -69.073% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1989.259% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -5099.172% |
| Palisade Bio, Inc. | 2.73 Million USD | -24669.806% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -12815.382% |
| Beam Therapeutics Inc. | 478.38 Million USD | -41.82% |
| Neurogene Inc. | 36.54 Million USD | -1756.261% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -70.485% |
| AEON Biopharma, Inc. | 159.88 Million USD | -324.322% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1323.809% |
| Sesen Bio, Inc. | 30.98 Million USD | -2089.662% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2513.324% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -8824.306% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -246.609% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -253.252% |
| Athira Pharma, Inc. | 30.05 Million USD | -2157.195% |
| Vaccinex, Inc. | 5.94 Million USD | -11317.789% |
| HCW Biologics Inc. | 15.05 Million USD | -4407.358% |
| XOMA Corporation | 145.58 Million USD | -366.029% |
| Nektar Therapeutics | 267.04 Million USD | -154.055% |
| Arvinas, Inc. | 644.6 Million USD | -5.251% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3725.862% |
| Merus N.V. | 102.15 Million USD | -564.159% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -363.577% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -613.252% |
| Rezolute, Inc. | 11.73 Million USD | -5681.873% |
| Clene Inc. | 38.95 Million USD | -1641.791% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -23726.992% |
| BeyondSpring Inc. | 48.26 Million USD | -1305.55% |
| Synlogic, Inc. | 32.89 Million USD | -1962.456% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4542.75% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -41420.502% |
| Peak Bio, Inc. | 20.75 Million USD | -3169.084% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -969.108% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1608.327% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -80.129% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -581.382% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -156683.97% |
| MannKind Corporation | 721.36 Million USD | 5.95% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2937.587% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -32423.73% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -561.317% |
| Gossamer Bio, Inc. | 249.14 Million USD | -172.307% |
| CohBar, Inc. | 1.03 Million USD | -65536.616% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -6247.133% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3461.765% |
| Legend Biotech Corporation | 589.93 Million USD | -15.004% |
| Mural Oncology plc | 37.92 Million USD | -1688.771% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -411.509% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -29457.598% |
| Disc Medicine, Inc. | 22.87 Million USD | -2865.88% |
| Champions Oncology, Inc. | 28.03 Million USD | -2319.993% |
| REGENXBIO Inc. | 262.22 Million USD | -158.723% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -20095.71% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -5312.837% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4951.101% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -3099.458% |
| Vaxart, Inc. | 34.02 Million USD | -1893.96% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3227.462% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2277.849% |
| Cellectis S.A. | 249.57 Million USD | -171.84% |
| Longeveron Inc. | 5.33 Million USD | -12612.104% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1522.337% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 71.793% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1023.849% |
| Revolution Medicines, Inc. | 262.39 Million USD | -158.557% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -32099.573% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -7765.117% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -5649.047% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4731.197% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -31440.911% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 86.826% |
| Denali Therapeutics Inc. | 122.96 Million USD | -451.747% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12091.517% |
| Veru Inc. | 32.81 Million USD | -1967.629% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -9776.911% |
| Cingulate Inc. | 10.36 Million USD | -6448.15% |
| Passage Bio, Inc. | 39.26 Million USD | -1627.994% |
| Context Therapeutics Inc. | 4.19 Million USD | -16085.38% |
| Exicure, Inc. | 8.54 Million USD | -7835.957% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2199.19% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -6370.008% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2978.104% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -316.26% |
| Nuvalent, Inc. | 31.82 Million USD | -2031.933% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -10564.646% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -976.521% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3669.139% |
| OmniAb, Inc. | 87.4 Million USD | -676.253% |
| Anew Medical, Inc. | 8.24 Million USD | -8131.759% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1671.901% |
| Lipocine Inc. | 2.63 Million USD | -25680.42% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2482.388% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1587.17% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2446.542% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -687.479% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -12461.47% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -719.903% |
| Ocugen, Inc. | 23.98 Million USD | -2728.858% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1361.945% |
| Q32 Bio Inc. | 233.12 Million USD | -191.018% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -7383.4% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1168.074% |
| Equillium, Inc. | 27.95 Million USD | -2326.745% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -228.398% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -11957.675% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -10962.262% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -331.235% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -877.122% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -6701.998% |
| Dominari Holdings Inc. | 4.63 Million USD | -14537.433% |
| Edesa Biotech, Inc. | 1.84 Million USD | -36739.236% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2194.602% |
| Bio-Techne Corporation | 744.34 Million USD | 8.853% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -438.026% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -96.961% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1572.076% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2242.94% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -634.566% |
| Nkarta, Inc. | 105.6 Million USD | -542.467% |
| BioCardia, Inc. | 4.59 Million USD | -14680.937% |
| Iterum Therapeutics plc | 32.66 Million USD | -1977.169% |